European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031 ...Middle East

Significant positive impact to Scinai's financial health is expected Amendment made in light of Scinai's recent strategic shift to development of nanosized antibody therapeutics aimed at inflammation and immunology diseases JERUSALEM , Nov. 29, 2023 /PRNewswire/ -- Scinai...

Hence then, the article about european investment bank eib extends maturity of its finance facility with scinai immunotherapeutics from 2027 to 2031 was published today ( Wednesday 29/11/2023 - 05:29 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031 )

Also on site :

• Denver Fire Department responds to 3-alarm fire at intersection of Leetsdale Drive and S. Forest Street
• Trial to begin for police officer charged in delayed response to Uvalde school shooting
• China’s special envoy meets Maduro (VIDEO)